Antiparkinson Agents < Antipsychotic Agents < Anxiety

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000004 (????)	F. Tison [France] ; J. Lecaroz ; L. Letenneur ; J F Dartigues	Parkinsonism and exposure to neuroleptic drugs in elderly people living in institutions.
000244 (2002)		Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000401 (2003)	A. Courtière [France] ; J. Hardouin ; A. Goujon ; F. Vidal ; T. Hasbroucq	Selective effects of low-dose dopamine D1 and D2 receptor antagonists on rat information processing.
000444 (2004)		Extrapyramidal reactions to SSRI antidepressant + neuroleptic combinations.
000449 (????)	V. Mesnage [France] ; J L Houeto ; A M Bonnet ; I. Clavier ; I. Arnulf ; F. Cattelin ; G. Le Fur ; P. Damier ; M L Welter ; Yves Agid	Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
000453 (????)	Nhan Nguyen [France] ; Vincent Pradel ; Joëlle Micallef ; Jean-Louis Montastruc ; Olivier Blin	[Drug-induced parkinson syndromes].
000536 (????)	C. Ricard [France] ; K. Martin ; M. Tournier ; B. Bégaud ; H. Verdoux	[A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].
000877 (2008)	M-A Crocq [France] ; V. Camus ; B. Millet ; J. Gliskman ; J-M Azorin ; M-O Krebs ; F. Limosin ; J. Costentin ; J. Daléry	[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
000C32 (2011)	Sylvie Bastuji-Garin [France] ; Pascal Joly ; Pauline Lemordant ; Agnès Sparsa ; Christophe Bedane ; Emmanuel Delaporte ; Jean-Claude Roujeau ; Philippe Bernard ; Jean-Claude Guillaume ; Saskia Ingen-Housz-Oro ; Hervé Maillard ; Catherine Pauwels ; Catherine Picard-Dahan ; Yes Dutronc ; Marie-Aleth Richard	Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
000D39 (2011)	Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret ; Haleh Bagheri ; Christine Brefel ; Olivier Rascol ; Jean-Louis Montastruc	Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.
000F89 (2012)	Alexandra Foubert-Samier [France] ; Catherine Helmer ; Florian Perez ; Mélanie Le Goff ; Sophie Auriacombe ; Alexis Elbaz ; Jean-François Dartigues ; François Tison	Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort.
001117 (2003)	Patrice Boyer [France]	Sense and non-sense of polypharmacy: increasing efficacy, decreasing compliance?
001213 (2013)	Roger D. Porsolt [France] ; Vincent Castagné ; Eric Hayes ; David Virley	Nonhuman primates: translational models for predicting antipsychotic-induced movement disorders.
001278 (2014)	L. Gaboriau [France] ; C. Victorri-Vigneau [France] ; M. Gérardin [France] ; G. Allain-Veyrac [France] ; P. Jolliet-Evin [France] ; M. Grall-Bronnec [France]	Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports.
001533 (2014)	H. Verdoux [France] ; E. Pambrun	Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample.
001783 (2015)	Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]	Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.
001860 (2015)	Margarita Garcia-Amador [Espagne] ; Jessica Merchán-Naranjo ; Cecilia Tapia ; Carmen Moreno ; Josefina Castro-Fornieles ; Inmaculada Baeza ; Elena De La Serna ; José A. Alda ; Daniel Mu Oz ; Patricia Andrés Nestares ; Carmen Martínez Cantarero ; Celso Arango	Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
001C27 (1987)	M. Ziegler [France] ; V. Fournier ; N. Bathien ; P L Morselli ; P. Rondot	Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
001C59 (1994)	M E Llau [France] ; L. Nguyen ; J M Senard ; O. Rascol ; J L Montastruc	[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
001E38 (1996)	P. Auzou [France] ; C. Ozsancak ; D. Hannequin ; N. Moore ; P. Augustin	Clozapine for the treatment of psychosis in Parkinson's disease: a review.
001E53 (1997)	F. Durif [France] ; M. Vidailhet ; F. Assal ; C. Roche ; A M Bonnet ; Yves Agid [France]	Low-dose clozapine improves dyskinesias in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Antipsychotic Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Antipsychotic Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antipsychotic Agents
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024